WHO global malaria strategy âoff track by a wide marginâ
HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating.
The World Health Organization has recommended a second vaccine for the prevention of malaria in children to overcome a shortage of medicine, particularly in.
HQ Team September 28, 2023: Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine.
HQ Team July 10, 2023: US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria..
HQ Team July 6, 2023: The UNICEF and the private-public partnership Gavi Vaccine Alliance will roll out its malaria vaccine for the first.
HQ Team June 27, 2023: For the first time in 20 years, locally-acquired cases of malaria have been detected in two US states,.
HQ Team April 19, 2023: The WHO called on Sudan’s warring factions to refrain from attacks on healthcare personnel, as about 270 people.
BioNTech, a Germany-based biotechnology company, is expected to spend between 2.4 million euros and 2.6 million euros on research this year compared with.
A third of the worldâs population has still not received a single dose of the Covid-19 vaccine, including 83% of all Africans, according.
BioNTech company starts trial for mRNA based malaria vaccine
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com